A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Blue Bird Corp (Symbol: BLBD) entered into oversold territory, hitting an RSI reading of 28 ...

Shares of Blue Bird Co. (NASDAQ:BLBD – Get Free Report) have been given an average rating of “Moderate Buy” by the eight brokerages that are currently covering the stock, Marketbeat.com reports.

Heliospace sensors and booms deploy aboard the Firefly Aerospace Blue Ghost Mission 1 lander BERKELEY, CALIFORNIA / ACCESS ...

Miami, FL, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (OTCQB: BSFC), a leading ...

Schauffele, winner of the PGA Championship and The Open Championship in 2024, to wear Blue Owl's logo on left sleeve across all PGA TOUR and major tournaments Schauffele will wear the Blue Owl ...

Blue Owl Capital Inc Class A (Symbol: OWL) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

(RTTNews) - Shift4 Payments, Inc. (FOUR) a US-based payment processing company, Tuesday announced that it is acquiring Global Blue ... reflect those of Nasdaq, Inc. Founded in the late 1990s ...

PATCHOGUE, N.Y., March 04, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island’s original craft brewery and a Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), proudly ...

Rosamond Price, Head of Private Wealth EMEA at Blue Owl said ... of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...

Sean Searby, the EVP Chief Info. & Ops. Officer of $AMAL, sold 3,000 shares of the company on 03-03-2025 for an estimated $97,470. We received data on the trade from ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

Fintel reports that on February 24, 2025, JP Morgan upgraded their outlook for bluebird bio (NasdaqGS:BLUE) from Underweight to Neutral. As of February 19, 2025, the average one-year price target ...